WS #12446
Holding: newest synthesis is 52d 19h old
Samsung Biologics bids $1.8 billion for PolyPeptide Group to expand into GLP-1 obesity drugs.
Samsung Biologics M&A
Samsung Biologics bids $1.8 billion for PolyPeptide Group to expand into GLP-1 obesity drugs.